Sintx Technologies, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sintx Technologies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 144,566% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 21% in 3 years; of every extra $100 of sales, $1,309 became extra profit. Higher than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 98% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-22.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 59% of Healthcare companies in United States.
Cash Locked Ratio
$78For every $100 of sales, $78 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $48 from others' credit three years earlier.
More money tied up than 98% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$1,309Sales grew 21% in 3 years; of every extra $100 of sales, $1,309 became extra profit.
Higher than 98% of Healthcare companies in United States.
Asset Productivity Ratio
+21% / -40%In 3 years sales changed by +21% while total assets changed by -40%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-1,224.4×Operating cash was negative last year, while some debt falls due within a year.
Lower than 98% of Healthcare companies in United States.
Cash Cushion Ratio
+7%Cash, after subtracting all debt, equals 7% of its market value (net cash).
Lower than 53% of Healthcare companies in United States.
Tangible Assets Ratio
95%Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 73% of Healthcare companies in United States.
Tangible Net Worth Ratio
85%Of every $100 of net worth, $85 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 66% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Sintx Technologies, Inc. made a loss over the last year. Sintx Technologies, Inc. owes $0.54 for every $1 it owns. Sintx Technologies, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSintx Technologies, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.57The share price is 2.57 times Sintx Technologies, Inc.'s book value per share, higher than 50% of Healthcare companies in United States.
Market cap
$12 MThe total market value of all of Sintx Technologies, Inc.'s shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$5 MWhat Sintx Technologies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.64Net worth divided by the number of shares. The share price of $1.64 is 2.6 times this, which is the P/B above.
Return on equity (ROE)
-255.9%Sintx Technologies, Inc. lost 255.9% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
Owes vs Owns
0.54×Sintx Technologies, Inc. owes $0.54 for every $1 it owns (moderate), higher than 60% of Healthcare companies in United States.
Dividend yield
NoneSintx Technologies, Inc. does not currently pay a dividend.
Revenue growth
-41%Revenue fell 41% in the year to Dec 2025, and grew 7% a year on average over 3 years.
Profit growth
LossSintx Technologies, Inc. made a loss in each of the last two years.
Profit margin
-1421.7%Sintx Technologies, Inc. lost $1422 for every $100 of revenue.
Interest cover
Not coveredSintx Technologies, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashSintx Technologies, Inc. held $1 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sintx Technologies, Inc.: $12 M ÷ $5 M (30 Jun 2026) = 2.6.
What is Sintx Technologies, Inc.'s return on equity?
Sintx Technologies, Inc. lost 255.9% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
How much does Sintx Technologies, Inc. owe compared with what it owns?
Sintx Technologies, Inc. owes $0.54 for every $1 it owns (moderate), higher than 60% of Healthcare companies in United States.
Does Sintx Technologies, Inc. pay a dividend?
No. Sintx Technologies, Inc. does not currently pay a dividend.
Is Sintx Technologies, Inc.'s revenue growing?
Revenue fell 41% in the year to Dec 2025, and grew 7% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.